Olema Pharmaceuticals, Inc.
Key Metrics
Market Snapshot
About
Olema Pharmaceuticals is a clinical-stage biopharmaceutical company developing targeted therapies for estrogen receptor-positive breast cancer. The company focuses on endocrine therapies designed to overcome resistance mechanisms in HR+ breast cancer. Olema's lead candidate is palazestrant, a complete estrogen receptor antagonist in clinical trials.